Literature DB >> 14730614

Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block.

Robert M Clancy1, Raj P Kapur, Yair Molad, Anca Dinu Askanase, Jill P Buyon.   

Abstract

OBJECTIVE: To assess in vivo the pathologic cascade leading to fibrosis in congenital heart block (CHB). In vitro studies suggest that CHB is initiated via apoptosis, resulting in translocation of SSA/Ro and SSB/La antigens and surface binding by maternal autoantibodies. These opsonized cardiocytes are phagocytosed by macrophages, which secrete factors inducing fibrosis.
METHODS: Immunohistochemistry analysis was performed on formalin-fixed sections of 4 fetal hearts identified in utero as having CHB or isolated myocarditis; mothers had anti-SSA/Ro and anti-SSB/La antibodies.
RESULTS: Apoptosis was most extensive in fetuses dying early and most pronounced in regions containing conduction tissue. Deposition of IgG was observed in hearts from fetuses with CHB/myocarditis, but not in 3 control hearts, and was colocalized with apoptotic cells. Giant cells and macrophages (frequently seen proximal to IgG and apoptotic cells) were present in septal and thickened fibrous subendocardial regions, most apparent in the youngest fetuses. Septal tissue also revealed extensive areas of fibrosis and microcalcification in which a predominant smooth muscle actin (SMA)-positive infiltrate (myofibroblast scarring phenotype) was observed. In contrast, there were no macrophages or SMA-positive cells (other than those lining blood vessels) in septal tissue from control hearts, although rare macrophages were seen in the working myocardium.
CONCLUSION: In summary, findings in this unique autopsy material paralleled those in in vitro studies. These data support the notion of exaggerated apoptosis, probably due to ongoing inflammation caused by IgG binding and ingestion by macrophages. Transdifferentiation of cardiac fibroblasts to a scarring phenotype may be a pathologic process initiated by maternal antibodies, and persistence of this phenotype even after birth may relate to the progression of block seen in some infants postpartum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730614     DOI: 10.1002/art.11430

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  55 in total

1.  Siglec-1 Macrophages and the Contribution of IFN to the Development of Autoimmune Congenital Heart Block.

Authors:  Robert M Clancy; Marc Halushka; Sara E Rasmussen; Tenzin Lhakhang; Miao Chang; Jill P Buyon
Journal:  J Immunol       Date:  2018-12-05       Impact factor: 5.422

2.  Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus.

Authors:  Carolina Llanos; Deborah M Friedman; Amit Saxena; Peter M Izmirly; Chung-E Tseng; Renata Dische; Rosanna G Abellar; Marc Halushka; Robert M Clancy; Jill P Buyon
Journal:  Rheumatology (Oxford)       Date:  2012-02-03       Impact factor: 7.580

3.  Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

Authors:  Amit Saxena; Peter M Izmirly; Sung Won Han; Paraskevi Briassouli; Tania L Rivera; Hua Zhong; Deborah M Friedman; Robert M Clancy; Jill P Buyon
Journal:  J Am Coll Cardiol       Date:  2015-08-25       Impact factor: 24.094

Review 4.  Autoantibodies in Sjögren's Syndrome.

Authors:  Anum Fayyaz; Biji T Kurien; R Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2016-06-21       Impact factor: 2.670

5.  Lupus: an overview of the disease and management options.

Authors:  William Maidhof; Olga Hilas
Journal:  P T       Date:  2012-04

Review 6.  Lupus and pregnancy: complex yet manageable.

Authors:  Josephine Patricia Dhar; Robert J Sokol
Journal:  Clin Med Res       Date:  2006-12

Review 7.  Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal / foetal dyad at risk.

Authors:  J P Buyon; R M Clancy; D M Friedman
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

8.  Binding of anti-SSA antibodies to apoptotic fetal cardiocytes stimulates urokinase plasminogen activator (uPA)/uPA receptor-dependent activation of TGF-β and potentiates fibrosis.

Authors:  Paraskevi Briassouli; Daniel Rifkin; Robert M Clancy; Jill P Buyon
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

Review 9.  The consequences of apoptosis in autoimmunity.

Authors:  Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-06-02       Impact factor: 7.094

10.  Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block.

Authors:  Robert M Clancy; David Alvarez; Elena Komissarova; Franck J Barrat; Jordan Swartz; Jill P Buyon
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.